Author:
O�ate-Oca�a Luis F.,Gallardo-Rinc�n Dolores,Aiello-Crocifoglio Vincenzo,Mondrag�n-S�nchez Ricardo,de-la-Garza-Salazar Jaime
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Secretaría de Salud, Asociación Mexicana de Patólogos AC. Instituto Nacional de Cancerología. Estómago. In: Secretaría de Salud, ed. Compendio del Registro Histopatológico de Neoplasias Malignas en México. Ciudad de México, México. Dirección General de Epidemiología; 1997: 77?81.
2. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy. Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the ?different disease? hypothesis. Cancer 2000;88:921?932.
3. Oñate-Ocaña LF, Aiello-Crocifoglio V, Mondragón-Sánchez R, Ruiz-Molina JM, Gallardo-Rincón D. Prognostic factors in 793 cases of gastric cancer. Rev Gastroenterol Mex 1999;64:114?121.
4. Gallardo-Rincón D, Oñate-Ocaña LF, Calderillo-Ruiz G. Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: A phase II study. Ann Surg Oncol 2000;7:45?50.
5. Ajani JA, Mansfield PF, Lynch PM, et al. Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol 1999;17:2403?2411.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献